Europe Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	213 Pages	Data Bridge Market Research	May, 2022	DAABD17330400

Best Price Guarantee
Price	from $3,500
Length	213 Pages
Publisher	Data Bridge Market Research
Published Date	May, 2022
SKU	DAABD17330400

Europe Psychedelic Drugs Market - Industry Trends and Forecast to 2029

Europe psychedelic drugs market is projected to register a substantial CAGR of 12.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:
Europe Psychedelic Drugs Market, By Source (Synthetic & Natural), Type (Empathogens, Dissociatives & Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, Others), Route of Administration (Oral, Inhalation, Injectable), End User (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)

Country (U.K., Germany, Italy, France, Spain, Russia, Poland, Netherland, Hungary, Austria, Norway, Switzerland, Ireland, Belgium, Lithuania and Rest of Europe) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the Europe psychedelic drugs market are:
• Rise in awareness towards mental health
• Growing Acceptance Of Psychedelic Drugs For Treating Depression

Market Players

The key market players for Europe psychedelic drugs market are listed below:
• Jazz Pharmaceuticals, Inc.
• Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.)
• Hikma Pharmaceuticals PLC
• COMPASS
• Verrian
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Avadel
• Celon Pharma SA.
• Cybin Corp.
• GH Research
• Entheon Biomedical Corp

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Europe Psychedelic Drugs Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market End User Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insight: 4.1 Pipeline Analysis; 4.2 Pestel Analysis; 4.3 Porter's Five Forces Model
5 Regulatory Framework: Europe Psychedelic Drugs Market: 5.1 Regulatory Scenario In The U.S.; 5.2 Regulatory Scenario In The U.K.; 5.3 Regulatory Scenario In India; 5.4 Regulatory Scenario In Uae; 5.5 Regulatory Scenario In Africa; 5.6 Regulatory Scenario In Brazil
6 Market Overview: 6.1 Drivers; 6.1.1 Growing Acceptance Of Psychedelic Drugs To Treat Depression; 6.1.2 Increasing Prevalence Of Depression And Mental Disorders; 6.1.3 Rising Awareness Toward Mental Health; 6.1.4 Ongoing Clinical Trials; 6.1.5 Rise In Product Approvals; 6.2 Restraints; 6.2.1 Stringent Regulations For Psychedelic Drugs; 6.2.2 High Cost Of Psychedelic Drugs; 6.2.3 Patent Expiry Of Psychedelic Drugs; 6.3 Opportunities; 6.3.1 Increasing R&D Activities In Psychedelic Drugs; 6.3.2 Breakthrough Therapy Designation By Regulatory Authority; 6.3.3 Upcoming Rehabilitation Centers; 6.3.4 Availability Of Certified Healthcare Professionals; 6.4 Challenges; 6.4.1 Side Effects Associated With Psychedelic Drugs; 6.4.2 Rise In Illegal Alternatives; 6.4.3 Availability Of Other Treatment Options
7 Covid-19 Impact On The Europe Psychedelic Drugs Market: 7.1 Impact On Price; 7.2 Impact On Demand; 7.3 Impact On Supply Chain; 7.4 Strategic Decisions For Manufacturers; 7.5 Conclusion
8 Europe Psychedelic Drugs Market, By Type: 8.1 Overview; 8.2 Empathogens; 8.3 Dissociatives; 8.4 Others
9 Europe Psychedelic Drugs Market, By Source: 9.1 Overview; 9.2 Synthetic; 9.3 Natural
10 Europe Psychedelic Drugs Market, By Drugs: 10.1 Overview; 10.2 Gamma-hydroxybutyric Acid; 10.3 Ketamine; 10.4 Psilocybin; 10.5 Others
11 Europe Psychedelic Drugs Market, By Application: 11.1 Overview; 11.2 Narcolepsy; 11.3 Treatment Resistant Depression; 11.4 Major Depressive Disorder; 11.5 Opiate Addiction; 11.6 Post-traumatic Stress Disorder; 11.7 Others
12 Europe Psychedelic Drugs Market, By Route Of Administration: 12.1 Overview; 12.2 Oral; 12.3 Inhalation; 12.4 Injectable
13 Europe Psychedelic Drugs Market, By End User: 13.1 Overview; 13.2 Hospitals; 13.3 Specialty Clinics; 13.4 Homecare; 13.5 Others
14 Europe Psychedelic Drugs Market, By Distribution Channel: 14.1 Overview; 14.2 Hospitals Pharmacy; 14.3 Retail Pharmacy; 14.4 Online Pharmacy
15 Europe Psychedelic Drugs Market, By Region: 15.1 Europe; 15.1.1 Germany; 15.1.2 U.K.; 15.1.3 France; 15.1.4 Italy; 15.1.5 Spain; 15.1.6 Russia; 15.1.7 Poland; 15.1.8 Switzerland; 15.1.9 Netherlands; 15.1.10 Hungary; 15.1.11 Austria; 15.1.12 Norway; 15.1.13 Ireland; 15.1.14 Belgium; 15.1.15 Lithuania; 15.1.16 Rest Of Europe
16 Europe Psychedelic Drugs Market: Company Landscape: 16.1 Company Share Analysis: Europe
17 Swot Analysis
18 Company Profile: 18.1 Jazz Pharmaceuticals, Inc.; 18.1.1 Company Snapshot; 18.1.2 Revenue Analysis; 18.1.3 Company Share Analysis; 18.1.4 Product Portfolio; 18.1.5 Recent Developments; 18.2 Pfizer Inc.; 18.2.1 Company Snapshot; 18.2.2 Revenue Analysis; 18.2.3 Company Share Analysis; 18.2.4 Product Portfolio; 18.2.5 Recent Developments; 18.3 F. Hoffmann- La Roche Ltd; 18.3.1 Company Snapshot; 18.3.2 Revenue Analysis; 18.3.3 Company Share Analysis; 18.3.4 Product Portfolio; 18.3.5 Recent Development; 18.4 Janssen Europe Services, Llc (A Subsidiary Of Johnson & Johnson Services, Inc.); 18.4.1 Company Snapshot; 18.4.2 Company Share Analysis; 18.4.3 Product Portfolio; 18.4.4 Recent Development; 18.5 Avadel; 18.5.1 Company Snapshot; 18.5.2 Product Portfolio; 18.5.3 Recent Development; 18.6 Celon Pharma Sa; 18.6.1 Company Snapshot; 18.6.2 Product Portfolio; 18.6.3 Recent Development; 18.7 Compass; 18.7.1 Company Snapshot; 18.7.2 Product Portfolio; 18.7.3 Recent Developments; 18.8 Cybin Corp.; 18.8.1 Company Snapshot; 18.8.2 Product Portfolio; 18.8.3 Recent Developments; 18.9 Entheon Biomedical Corp; 18.9.1 Company Snapshot; 18.9.2 Product Portfolio; 18.9.3 Recent Development; 18.10 Gh Research; 18.10.1 Company Snapshot; 18.10.2 Product Portfolio; 18.10.3 Recent Development; 18.11 Hikma Pharmaceuticals Plc; 18.11.1 Company Snapshot; 18.11.2 Revenue Analysis; 18.11.3 Product Portfolio; 18.11.4 Recent Developments; 18.12 Nrx Pharmaceuticals, Inc.; 18.12.1 Company Snapshot; 18.12.2 Product Portfolio; 18.12.3 Recent Development; 18.13 Pharmather Holdings Ltd.; 18.13.1 Company Snapshot; 18.13.2 Product Portfolio; 18.13.3 Recent Development; 18.14 Verrian; 18.14.1 Company Snapshot; 18.14.2 Product Portfolio; 18.14.3 Recent Development; 18.15 Usonainstitute.Org; 18.15.1 Company Snapshot; 18.15.2 Product Portfolio; 18.15.3 Recent Development
19 Questionnaire
20 Related Reports
List Of Tables: Table 1 Europe Psychedelic Drugs Market, Pipeline Analysis; Table 2 Psychedelics Research Studies, In Europe; Table 3 Mental Illness In The U.S. Adults, In 2020; Table 4 Mental Disorders, In The U.S. Adults, In 2020; Table 5 Drug Development Pathway For Fda Approval Of New Medications; Table 6 The 1971 Un Convention On Psychotropic Substances; Table 7 Magic Mushrooms Prices For Researchers, In The U.S.; Table 8 Cost Of Psychedelic Drugs; Table 9 Psychedelic Drugs R&D Activities; Table 10 Europe Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 11 Europe Empathogens In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 12 Europe Dissociatives In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 13 Europe Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 14 Europe Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 15 Europe Synthetic In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 16 Europe Natural In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 17 Europe Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 18 Europe Gamma-hydroxybutyric Acid In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 19 Europe Ketamine In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 20 Europe Psilocybin In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 21 Europe Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 22 Europe Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 23 Europe Narcolepsy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 24 Europe Treatment Resistant Depression In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 25 Europe Major Depressive Disorder In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 26 Europe Opiate Addiction In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 27 Europe Post-traumatic Stress Disorder In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 28 Europe Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 29 Europe Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 30 Europe Oral In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 31 Europe Inhalation In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 32 Europe Injectable In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 33 Europe Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 34 Europe Hospitals In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 35 Europe Specialty Clinics In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 36 Europe Homecare In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 37 Europe Others In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 38 Europe Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 39 Europe Hospitals Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 40 Europe Retail Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 41 Europe Online Pharmacy In Psychedelic Drugs Market, By Region, 2020-2029 (Usd Million); Table 42 Europe Psychedelic Drugs Market, By Country, 2020-2029 (Usd Million); Table 43 Europe Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 44 Europe Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 45 Europe Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 46 Europe Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 47 Europe Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 48 Europe Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 49 Europe Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 50 Germany Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 51 Germany Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 52 Germany Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 53 Germany Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 54 Germany Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 55 Germany Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 56 Germany Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 57 U.K. Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 58 U.K. Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 59 U.K. Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 60 U.K. Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 61 U.K. Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 62 U.K. Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 63 U.K. Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 64 France Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 65 France Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 66 France Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 67 France Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 68 France Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 69 France Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 70 France Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 71 Italy Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 72 Italy Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 73 Italy Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 74 Italy Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 75 Italy Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 76 Italy Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 77 Italy Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 78 Spain Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 79 Spain Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 80 Spain Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 81 Spain Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 82 Spain Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 83 Spain Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 84 Spain Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 85 Russia Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 86 Russia Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 87 Russia Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 88 Russia Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 89 Russia Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 90 Russia Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 91 Russia Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 92 Poland Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 93 Poland Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 94 Poland Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 95 Poland Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 96 Poland Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 97 Poland Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 98 Poland Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 99 Switzerland Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 100 Switzerland Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 101 Switzerland Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 102 Switzerland Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 103 Switzerland Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 104 Switzerland Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 105 Switzerland Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 106 Netherlands Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 107 Netherlands Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 108 Netherlands Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 109 Netherlands Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 110 Netherlands Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 111 Netherlands Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 112 Netherlands Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 113 Hungary Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 114 Hungary Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 115 Hungary Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 116 Hungary Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 117 Hungary Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 118 Hungary Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 119 Hungary Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 120 Austria Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 121 Austria Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 122 Austria Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 123 Austria Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 124 Austria Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 125 Austria Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 126 Austria Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 127 Norway Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 128 Norway Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 129 Norway Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 130 Norway Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 131 Norway Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 132 Norway Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 133 Norway Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 134 Ireland Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 135 Ireland Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 136 Ireland Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 137 Ireland Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 138 Ireland Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 139 Ireland Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 140 Ireland Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 141 Belgium Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 142 Belgium Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 143 Belgium Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 144 Belgium Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 145 Belgium Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 146 Belgium Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 147 Belgium Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 148 Lithuania Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million); Table 149 Lithuania Psychedelic Drugs Market, By Source, 2020-2029 (Usd Million); Table 150 Lithuania Psychedelic Drugs Market, By Drugs, 2020-2029 (Usd Million); Table 151 Lithuania Psychedelic Drugs Market, By Application, 2020-2029 (Usd Million); Table 152 Lithuania Psychedelic Drugs Market, By Route Of Administration, 2020-2029 (Usd Million); Table 153 Lithuania Psychedelic Drugs Market, By End User, 2020-2029 (Usd Million); Table 154 Lithuania Psychedelic Drugs Market, By Distribution Channel, 2020-2029 (Usd Million); Table 155 Rest Of Europe Psychedelic Drugs Market, By Type, 2020-2029 (Usd Million)
List Of Figures: Figure 1 Europe Psychedelic Drugs Market: Segmentation; Figure 2 Europe Psychedelic Drugs Market : Data Triangulation; Figure 3 Europe Psychedelic Drugs Market: Droc Analysis; Figure 4 Europe Psychedelic Drugs Market: Europe Vs Regional Market Analysis; Figure 5 Europe Psychedelic Drugs Market: Company Research Analysis; Figure 6 Europe Psychedelic Drugs Market: Multivariate Modelling; Figure 7 Europe Psychedelic Drugs Market: Interview Demographics; Figure 8 Europe Psychedelic Drugs Market: Dbmr Market Position Grid; Figure 9 Europe Psychedelic Drugs Market: End User Coverage Grid; Figure 10 Europe Psychedelic Drugs Market: Vendor Share Analysis; Figure 11 Europe Psychedelic Drugs Market: Segmentation; Figure 12 North America Is Expected To Dominate The Europe Psychedelic Drugs Market Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029; Figure 13 Rising Awareness Towards Merantal Health Driving The Europe Psychedelic Drugs Market In The Forecast Period Of 2022 To 2029; Figure 14 Empathogens Segment Is Expected To Account For The Largest Share Of The Europe Psychedelic Drugs Market In 2022 & 2029; Figure 15 Drivers, Restraints, Opportunities, And Challenges Of The Europe Psychedelic Drugs Market; Figure 16 Mental Illness Among The U.S. Adults, In 2020, (In %), By Demographic Groups; Figure 17 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Demographic Groups; Figure 18 Mental Illness Treatment Rates Among The U.S. Adults, In 2020, (In %), By Gender; Figure 19 Europe Psychedelic Drugs Market: By Type, 2021; Figure 20 Europe Psychedelic Drugs Market: By Type, 2022-2029 (Usd Million); Figure 21 Europe Psychedelic Drugs Market: By Type, Cagr (2022-2029); Figure 22 Europe Psychedelic Drugs Market: By Type, Lifeline Curve; Figure 23 Europe Psychedelic Drugs Market: By Source, 2021; Figure 24 Europe Psychedelic Drugs Market: By Source, 2022-2029 (Usd Million); Figure 25 Europe Psychedelic Drugs Market: By Source, Cagr (2022-2029); Figure 26 Europe Psychedelic Drugs Market: By Source, Lifeline Curve; Figure 27 Europe Psychedelic Drugs Market: By Drugs, 2021; Figure 28 Europe Psychedelic Drugs Market: By Drugs, 2022-2029 (Usd Million); Figure 29 Europe Psychedelic Drugs Market: By Drugs, Cagr (2022-2029); Figure 30 Europe Psychedelic Drugs Market: By Drugs, Lifeline Curve; Figure 31 Europe Psychedelic Drugs Market: By Application, 2021; Figure 32 Europe Psychedelic Drugs Market: By Application, 2022-2029 (Usd Million); Figure 33 Europe Psychedelic Drugs Market: By Application, Cagr (2022-2029); Figure 34 Europe Psychedelic Drugs Market: By Application, Lifeline Curve; Figure 35 Europe Psychedelic Drugs Market: By Route Of Administration, 2021; Figure 36 Europe Psychedelic Drugs Market: By Route Of Administration, 2022-2029 (Usd Million); Figure 37 Europe Psychedelic Drugs Market: By Route Of Administration, Cagr (2022-2029); Figure 38 Europe Psychedelic Drugs Market: By Route Of Administration, Lifeline Curve; Figure 39 Europe Psychedelic Drugs Market: By End User, 2021; Figure 40 Europe Psychedelic Drugs Market: By End User, 2022-2029 (Usd Million); Figure 41 Europe Psychedelic Drugs Market: By End User, Cagr (2022-2029); Figure 42 Europe Psychedelic Drugs Market: By End User, Lifeline Curve; Figure 43 Europe Psychedelic Drugs Market: By Distribution Channel, 2021; Figure 44 Europe Psychedelic Drugs Market: By Distribution Channel, 2022-2029 (Usd Million); Figure 45 Europe Psychedelic Drugs Market: By Distribution Channel, Cagr (2022-2029); Figure 46 Europe Psychedelic Drugs Market: By Distribution Channel, Lifeline Curve; Figure 47 Europe Psychedelic Drugs Market: Snapshot (2021); Figure 48 Europe Psychedelic Drugs Market: By Country (2021); Figure 49 Europe Psychedelic Drugs Market: By Country (2022 & 2029); Figure 50 Europe Psychedelic Drugs Market: By Country (2021 & 2029); Figure 51 Europe Psychedelic Drugs Market: By Type (2022-2029); Figure 52 Europe Psychedelic Drugs Market: Company Share 2021 (%)